From Alphastreet - Earnings Decoded. Market Intelligence Delivered · AlphaStreet Newsdesk · · 1m 10s
Sono-Tek Q2 2027 EPS Miss
Sono-Tek's Q2 2027 earnings miss reveals medical growth surge amid operational challenges.
In brief
Sono-Tek's Q2 2027 earnings miss reveals medical growth surge amid operational challenges. Sono-Tek's Q2 2027 EPS fell to $0.02, 50% below estimates, as medical revenue surged 209% to $3.1M while legacy segments declined. Originally reported by Alphastreet - Earnings Decoded. Market Intelligence Delivered.
Sono-Tek Q2 2027 Earnings
Sono-Tek Corporation delivered a disappointing miss in Q2 2027 with GAAP EPS of $0.02 falling 50% short of the $0.04 consensus estimate.
Revenue Growth vs Earnings
The company reported a modest 1% year-over-year revenue increase to $5.2M despite a 50% EPS miss.
Medical Segment Surge
Medical revenue surged 209% to $3.1M, representing 59% of total quarterly revenue.
Legacy Segment Decline
Electronics/Microelectronics declined 17% to $1.2M while Multi-Axis Coating Systems fell 3% to $2.0M.
Margin Divergence
Net margin improved to 7% from 8.1% a year ago while net income declined 14% to $366,000.
Backlog Conversion
The $9.5M equipment and service backlog provides revenue visibility but raises questions about conversion efficiency.
What to Watch
Monitor medical revenue sustainability and whether the 209% growth rate represents a one-time inflection or sustained expansion.
At a glance
Sono-Tek's Q2 2027 EPS fell to $0.02, 50% below estimates, as medical revenue surged 209% to $3.1M while legacy segments declined.
